DCM
KITE

Dialectic Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Dialectic Capital Management’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.8M Buy
+23,000
New +$1.42M 1.16% 25
2015
Q4 		– Sell
-5,000
Closed -$352K – 189
2015
Q3 		$278K Buy
+5,000
New +$315K 0.09% 132

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dialectic Capital Management's KITE Position: Q1 2017 in Review

Dialectic Capital Management opened a new position in Kite Pharma, Inc. (KITE) in Q1 2017: 23,000 shares worth $1.8M. The stake represents 1.16% of the portfolio and ranks #25 among its holdings. This is a return to the name: Dialectic Capital Management previously reported a position in KITE as recently as Q3 2015.

Dialectic Capital Management first reported a position in KITE in Q3 2015 and has held it in 2 quarters since. 209 funds tracked by Wall St. Rank hold KITE as of Q1 2017.

  • Dialectic Capital Management held 23,000 shares of Kite Pharma, Inc. worth $1.8M as of Q1 2017.
  • Kite Pharma, Inc. was a new Dialectic Capital Management position in Q1 2017.
  • Kite Pharma, Inc. made up 1.16% of Dialectic Capital Management's portfolio in Q1 2017, its #25 holding.
  • Dialectic Capital Management first reported a position in Kite Pharma, Inc. in Q3 2015 and has held it in 2 quarters since.
  • 209 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2017.

Based on Dialectic Capital Management's 13F filing for Q1 2017, filed 11 May 2017.